Related Experiment Video
Updated: Jan 26, 2026
05:56
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
5.2K
Personalized Medicine and Pediatric Asthma
Nathan M Pajor1, Theresa W Guilbert2
1Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7041, Cincinnati, OH 45229, USA.
Immunology and Allergy Clinics of North America
|April 8, 2019
Summary
Asthma management is improving through a personalized, phenotype-based approach. Understanding specific asthma types and utilizing targeted therapies will enhance treatment outcomes for children.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Clinical Medicine
Background:
- Asthma is a complex respiratory condition with diverse clinical presentations.
- Recent research highlights the importance of identifying specific asthma phenotypes.
- A phenotype-based approach tailors management to individual patient and disease characteristics.
Purpose of the Study:
- To review the evidence supporting a phenotype-based approach to asthma management.
- To discuss the implications of emerging therapies and phenotypic markers for pediatric asthma.
- To underscore the potential for improved asthma control through personalized medicine.
Main Methods:
- Literature review of studies on asthma phenotypes and treatment strategies.
- Analysis of current and emerging therapeutic options for pediatric asthma.
- Examination of advancements in phenotypic markers for asthma classification.
Main Results:
- Evidence supports that asthma heterogeneity necessitates tailored treatment strategies.
- A growing number of targeted therapies are becoming available for pediatric asthma.
- New phenotypic markers are enhancing the ability to classify asthma subtypes.
Conclusions:
- A phenotype-based approach is crucial for optimizing asthma management.
- Personalized medicine, driven by phenotypic understanding, promises better outcomes for children with asthma.
- Future advancements in therapies and biomarkers will further refine asthma care.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:29Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
01:26Asthma-II: Pathophysiology and Classification
4.2K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.2K
01:20Asthma: Pathogenesis and Management
1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
01:24Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K